They also found that autoantibodies against PD-L1 in rheumatoid arthritis patients acted on primary CD4+ T-cells to promote apoptosis of activated CD4+ T-cells in an interleukin-10 (IL-10)-dependent manner. Here, IL10 is linked to rheumatoid arthritis.